Although not statistically significant (adjusted p = 0.19, 0.22, and 0.07 for C1- vs. C2-AITL, C1-AITL vs. C3-AITL, and C2-AITL vs. C3-AITL, respectively, Fig. S24), the number of CD10-positive cases (12/26 [46.2%], 0/4 [0%], and 13/19 [68.4%] for C1, C2, and C3-AITL, respectively) suggests that the C3-subtype in the current analysis seemed to correspond to classical AITL. This evidence concerns the gene MME and angioimmunoblastic T-cell lymphoma.